Blog
RSS FeedPosted by Michael Wonder on 17 Jan 2025
International collaboration provides new guidance on the use of surrogate outcomes in cost effectiveness analysis
17 January 2025 - Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits ...
Posted by Michael Wonder on 31 Oct 2023
NICE launches first modular update to its methods and processes
31 October 2023 - NICE’s methods and processes now include a proportionate approach to technology appraisals, and a new way of ...
Posted by Michael Wonder on 09 Oct 2023
The evolving nature of health technology assessment: a critical appraisal of NICE’s new methods manual
6 October 2023 - NICE recently completed a review of its methods for health technology assessment, involving a 2 stage ...
Posted by Michael Wonder on 27 Jun 2023
NICE launches public consultation on updates to health technology evaluations manual
27 June 2023 - A public consultation on updates to NICE’s health technology evaluations manual is now open. ...
Posted by Michael Wonder on 07 Jun 2022
Global expert panel publishes guidance on deliberative processes for health technology assessment
7 June 2022 - Value in Health announced today the publication of guidance regarding the establishment or improvement of deliberative ...
Posted by Michael Wonder on 30 May 2022
NICE sets out further details on menopause guideline update
27 May 2022 - NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where ...
Posted by Michael Wonder on 31 Jan 2022
NICE publishes new combined methods and processes manual and topic selection manual for its health technology evaluation programmes
31 January 2022 - Changes to the way medicines and other health technologies are evaluated by NICE have now been incorporated ...
Posted by Michael Wonder on 14 Jan 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
11 January 2022 - The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. ...
Posted by Michael Wonder on 16 Dec 2021
NICE recommends offering PrEP to people at high risk of HIV for first time
15 December 2021 - People at the highest risk of catching HIV should be offered pre-exposure prophylaxis, NICE has recommended for ...
Posted by Michael Wonder on 27 Nov 2021
Can we trust strong recommendations based on low quality evidence?
25 November 2021 - A necessary requirement for development of trustworthy guidelines is to respect the relation between the quality (certainty) ...
Posted by Michael Wonder on 23 Mar 2021
NICE publishes single guideline for managing COVID-19
23 March 2021 - One year on from the first national lockdown, NICE has today published a single guideline for the ...
Posted by Michael Wonder on 07 Feb 2021
Modifying NICE’s approach to equity weighting
7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...
Posted by Michael Wonder on 07 Feb 2021
NICE’s discounting review: clear thinking on rational revision meets obstacle of industrial interests
7 February 2021 - NICE recently published a review of discounting practice and theory as part of a consultation on ...
Posted by Michael Wonder on 04 Feb 2021
NICE’s processes of technology evaluation - presenting a case for change
4 February 2021 - NICE has today launched a public consultation on proposals for changes to the processes it uses to ...
Posted by Michael Wonder on 06 Nov 2020
NICE’s methods of technology evaluation - presenting a case for change
6 November 2020 - NICE has today launched a public consultation on proposals for changes to the methods it uses to ...